
Explore updates to ISCN 2024 and preview new genomic mapping nomenclature. Gain insights into evolving standards for clinical cancer genomics and their impact on patient care.

Explore the continued relevance of cytogenetics in modern genomics, highlighting its crucial role in cancer diagnosis and treatment strategies.

Explore standardized classification of oncogenic somatic variants in cancer, improving consistency through validated SOP and real-world case demonstrations.

Explore NPM1 mutations in myeloid malignancies and their impact on precision medicine through molecular testing. Gain insights from expert Robert Hasserjian on advancing cancer diagnostics and treatment.

Explore cutting-edge cancer genomics research, focusing on childhood brain tumors and ovarian cancer. Gain insights into copy number alterations, single-cell RNA sequencing, and their impact on patient outcomes.

Explore the intersection of pathology and bioinformatics in next-generation curating for cancer genomics. Gain insights into best practices and advancements in clinical cancer genomic testing.

Explore the relationship between genetic ancestry, somatic alterations, and cancer outcomes in this insightful presentation by Jian Carrot-Zhang at the 2022 CGC Annual Meeting.

Explore cutting-edge cancer genomics research with presentations on cell-type-specific breast genotyping and standardized assessment of NTRK fusions.

Explore complex cancer genome structures through long molecule footprints. Gain insights into advanced genomic analysis techniques for accurate cancer diagnosis and personalized treatment.

Explore leveraging SNP arrays in cancer genomics beyond CNVs, focusing on mosaic gains/losses, HRD scores, and noninformative SNPs for improved diagnosis and treatment.

Explore chikungunya arthritis and dengue vascular permeability studies, focusing on translational science in arboviral pathogen research.

Explore clinical NGS implementation at Holycross Cancer Center, focusing on challenges, solutions, and future directions in molecular diagnostics for cancer care.

Explore molecular profiling of NSCLC samples using the Genexus turnkey NGS platform with Dr. Brendan Pang, a consultant pathologist and medical director.

Explore translational research strategies through RENACER example, enhancing impact of scientific discoveries in clinical settings.

Explore groundbreaking research on TRAIL's role in breast cancer metastasis, uncovering its function as a vascular gatekeeper and its therapeutic potential in preventing premetastatic niche formation.

Learn to translate human-readable genetic variation descriptions into unique computable variations using the Variation Normalizer tool for improved cancer genomics analysis and diagnosis.

Explore co-occurring driver mutations in lung adenocarcinoma, their impact on RAS signaling, and implications for targeted therapies. Gain insights into clinical cases and treatment strategies.

Explore epigenetic reprogramming in brain development pathways during non-small cell lung cancer metastasis. Gain insights into cutting-edge cancer genomics research and its implications for diagnosis and treatment.

Explore computational methods for predicting MHC anchor locations to enhance neoantigen identification and prioritization in cancer genomics, improving patient diagnosis and treatment.

Explore techniques for accurate somatic RNA variant calling in solid tumors, addressing key challenges and improving cancer genomics analysis.

Explore cutting-edge ABEL Trap fluorescence spectroscopy for observing single-molecule biomolecular interactions, presented by Dr. Allison Squires of the University of Chicago.